Literature DB >> 22277287

Endometrial cancer.

Vivek Arora1, Michael A Quinn.   

Abstract

Endometrial carcinoma is the most common gynaecological malignancy in the Western world. The standard management of endometrial carcinoma is total hysterectomy and bilateral salpingo-oophorectomy with or without pelvic and para-aortic lymph-node dissection. Increasingly, endometrial cancer is being diagnosed in younger women in whom preserving fertility may be an important consideration when deciding optimal management. Conservative management of endometrial carcinoma may be a therapeutic option in carefully selected women with well-differentiated endometrial cancer in the absence of any myometrial invasion or adnexal disease seen on imaging. The biggest concern with conservative management of endometrial carcinoma is disease progression while on treatment or after initial response to medical treatment. Women opting for conservative management should be aware that hormonal therapy is not the standard form of management. Potential adverse outcomes should be taken into consideration. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22277287     DOI: 10.1016/j.bpobgyn.2011.12.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  14 in total

1.  Endometrial Cancer: Hidden Pathology in a Patient with Abnormal Uterine Bleeding and Known Leiomyoma.

Authors:  Trisha Sri; Albert J Steren; Pamela Stratton
Journal:  Gynecol Obstet Invest       Date:  2015-01-27       Impact factor: 2.031

2.  PGC1α and VDAC1 expression in endometrial cancer.

Authors:  Ofra Castro Wersäll; Lina Löfstedt; Igor Govorov; Miriam Mints; Marike Gabrielson; Maria Shoshan
Journal:  Mol Clin Oncol       Date:  2020-12-30

3.  Endometrial Carcinoma: Texture Analysis of Apparent Diffusion Coefficient Maps and Its Correlation with Histopathologic Findings and Prognosis.

Authors:  Ichiro Yamada; Naoyuki Miyasaka; Daisuke Kobayashi; Kimio Wakana; Noriko Oshima; Akira Wakabayashi; Junichiro Sakamoto; Yukihisa Saida; Ukihide Tateishi; Yoshinobu Eishi
Journal:  Radiol Imaging Cancer       Date:  2019-11-29

4.  Development of a 4-miRNA prognostic signature for endometrial cancer.

Authors:  Jiazhen Huang; Furong Du; Ning Wang
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

5.  Androgen receptor increases CD133 expression and progenitor-like population that associate with cisplatin resistance in endometrial cancer cell line.

Authors:  Lumin Chen; Wei-Chun Chang; Yao-Ching Hung; Ying-Yi Chang; Bo-Yin Bao; Hsin-Ching Huang; Wei-Min Chung; Chih-Rong Shyr; Wen-Lung Ma
Journal:  Reprod Sci       Date:  2013-08-20       Impact factor: 3.060

6.  Protopanaxadiol and metformin synergistically inhibit estrogen-mediated proliferation and anti-autophagy effects in endometrial cancer cells.

Authors:  Chun-Jie Gu; Jiao Cheng; Bing Zhang; Shao-Liang Yang; Feng Xie; Jian-Song Sun; Li-Qing Huang; Jin-Jin Yu; Ming-Qing Li
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

7.  Identification of histological features of endometrioid adenocarcinoma based on amide proton transfer-weighted imaging and multimodel diffusion-weighted imaging.

Authors:  Fangfang Fu; Nan Meng; Zhun Huang; Jing Sun; Xuejia Wang; Jie Shang; Ting Fang; Pengyang Feng; Kaiyu Wang; Dongming Han; Meiyun Wang
Journal:  Quant Imaging Med Surg       Date:  2022-02

8.  Imaging in endometrial carcinoma.

Authors:  Silvana C Faria; Tara Sagebiel; Aparna Balachandran; Catherine Devine; Chandana Lal; Priya R Bhosale
Journal:  Indian J Radiol Imaging       Date:  2015 Apr-Jun

9.  The prognostic significance of tumour-stroma ratio in endometrial carcinoma.

Authors:  Hannah Panayiotou; Nicolas M Orsi; Helene H Thygesen; Alexander I Wright; Matthew Winder; Richard Hutson; Michele Cummings
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

10.  The MCM3AP-AS1/miR-126/VEGF axis regulates cancer cell invasion and migration in endometrioid carcinoma.

Authors:  Jie Yu; Qiqi Fan; Lingling Li
Journal:  World J Surg Oncol       Date:  2021-07-13       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.